Israel’s Kadimastem’s recent news includes success in pre-clinical tests of its stem cell treatment for ALS. The technology also induces pancreatic cells to produce insulin and Kadimastem has begun research with Ramot, Tel Aviv University’s technology transfer company.

http://www.israel21c.org/headlines/stem-cell-therapy-for-als-diabetes/